Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 12.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Lung Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 172 100.0% 6,630 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 10 5.8% 400 6.0%
OKT3     44 0.7%
Thymoglobulin 8 4.7% 278 4.2%
Zenapax 19 11.0% 990 14.9%
Simulect 48 27.9% 1,641 24.8%
Campath 19 11.0% 499 7.5%
Rituximab     20 0.3%
No Induction Drug Reported 71 41.3% 2,826 42.6%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.